Summaryas a hydrogen carrier between cytoplasmic-reduced glutathione (which appears to penetrate membranes poorly) and &tralysoso-Cysteamine is the most effective agent known for the reduction mal cystine. A genetic deficiency in endogenous cystearnine genof the elevated cystine content of cells from patients with cysti-eration might therefore lead to diminished capacity for intralysonosis. A defect in endogenous cysteamine generation could ac-somal reduction of cysthe to cysteke, a molecule to which the count for many of the metabolic features of this disorder. To test lysosomal membrane should be permeable (33) and hence could this we have for measur-be the fundamental etiology of abnormal cysthe accumulation in ing pantetheinase (cysteamine-generating) activity and intracellu-cystinosis. lar cysteamine levels and used these methods to measure such Cystearnine ( (4,6,8,9,(14)(15)(16)(17). 9.4 f 1.5; cystinotic, 7.7 2 1.71. Cysteamine levels were normal in There is some evidence that pantetheinase is present in both leukocytes from c~stinotics receiving no 'ysteamine Or doses of soluble and lysosomal-microsomal cell fractions. This enzyme has oral cysteamine too low to reduce leukocyte cystine content. The not previously been described in human cells or tissues. results indicate that the cause of cystinosis is unlikely to be related Pantetheinase activity has been determined by several methods. to a failure to generate or sustain normal intracellular cysteamine levels.One involves quantitation of pantothenic acid (PoA), an end product of PTSH cleavage, using a microbiological assay in which PoA is a necessary growth factor (e.g., using Lactobacillus arabiSpeculation nosus) (2, 5, 9, 10, 39). The radiochemical assay of Dupre et al. (6, cystearnine is an extremely effective cystine depleting agent for 14-17) utilizes labeled PTSH as substrate and measures radioaccystinotic fibroblasts in vitro and can greatly reduce cystinotic tive product after PTSH. A pHleukocyte cystine content in vivo. Its pharmacologic properties Stat has been proposed (l l). The first is time suggest that it might prove to be of value in the therapy of consuming and proved erratic in our hands, whereas the radicystinosis. However, we do not believe that a defect in endogenous Ochemical assay requires an radiolabeled substrate cysteamine generation is a characteristic of cystinotic cells. The which must be We therefore a eventual elucidation of the cystinotic defect may require analysis system for low levels pantetheinase of the permeability characteristics of cystinotic ~ysosomes or the activity in small cell samples; our assay involves rapid quantitation discovery of presently unidentified pathways for lysosomal metab-MEA On an acid after generation PTSH olism of cystine.and reaction with N-ethylmaleimide (NEM). The present report describes our use of this new method to determine panthetheinase activity and define certain properties of Cystinosis, a metabolic disease inherited as an autosomal Feces-this enzyme in extracts of cultured skin ...